COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,190 Articles (22,713 medRxiv, 8,477 bioRxiv)

Most recent first Previous |  Page 222: Articles 2211-2220  | Next

SARS-CoV-2 spike S2 subunit inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in cancer cells
Zhang, S., El-Deiry, W. S.
10.1101/2024.04.12.589252 — Posted: 2024-04-15
SARS-CoV-2 Antigen Rapid Detection Tests: test performance during the COVID-19 pandemic and the impact of COVID-19 vaccination
Wagenhäuser, I., Knies, K., Pscheidl, T., Eisenmann, M., Flemming, S., Petri, N., McDonogh, M., Scherzad, A., Zeller, D., Gesierich, A., Seitz, A. K., Taurines, R., Ernestus, R.-I., Forster, J., Weismann, D., Weissbrich, B., Liese, J., Härtel, C., Kurzai, O., Dölken, L., Gabel, A., Krone, M.
10.1101/2024.04.11.24304791 — Posted: 2024-04-14
Deaths averted by COVID-19 vaccination in select Latin American and Caribbean Countries: a modelling study
Savinkina, A., Weinberger, D., Toscano, C., De Oliviera, L. H.
10.1101/2024.04.12.24305739 — Posted: 2024-04-14
Impact of COVID-19 on diabetes mellitus outcomes and care in sub-Saharan Africa: A scoping review
Sseguya, W., Bahendeka, S., MacLennan, S., Mody, N., Guntupalli, A. M.
10.1101/2024.04.10.24305598 — Posted: 2024-04-13
MAJOR METABOLITES FROM HYPERICUM PERFORATUM L., HYPERFORIN AND HYPERICIN, ARE BOTH ACTIVE AGAINST HUMAN CORONAVIRUSES
Raczkiewicz, I., Riviere, C., Bouquet, P., Desmarets, L., Tarricone, A., Camuzet, C., Francois, N., Lefevre, G., Samaillie, J., Silva Angulo, F., Robil, C., Trottein, F., Sahpaz, S., Dubuisson, J. D., Belouzard, S., Goffard, A., Seron, K.
10.1101/2024.04.09.588755 — Posted: 2024-04-13
Data rectification to account for delays in reporting disease incidence with an application to forecasting COVID-19 cases
Abdussalam, Y. A., Roberts, S., Aguilar, J. B., Kercheville, J., Gutierrez, J. B.
10.1101/2024.04.08.24305398 — Posted: 2024-04-12
Incidence and Risk of Post-COVID-19 Thromboembolic Disease and the Impact of Aspirin Prescription; Nationwide Observational Cohort at the US Department of Veteran Affairs.
Ware, A., Veigulis, Z. P., Hoover, P. J., Blumke, T., Ioannou, G. N., Boyko, E. J., Osborne, T.
10.1101/2024.04.10.24305647 — Posted: 2024-04-12
Application of a High-Resolution Melt Assay for Monitoring SARS-CoV-2 Variants in Burkina Faso and Kenya
Greenland-Bews, C., Shah, S., Achieng, M., Badoum, E. S., Bah, Y., Barsosio, H. C., Brazal-Monzo, H., Canizales, J., Drabko, A., Fraser, A. J., Hannan, L., Jarju, S. J., Kabore, J.-M. T., Kujabi, M. A., Lesosky, M., Manneh, J., Marlais, T., Matthewman, J., Nebie, I., Onyango, E. D., Ouedraogo, A., Otieno, K., Serme, S. S., Sirima, S. B., Soulama, B. I., Tangara, B., Tiono, A. B., Wu, W., Sesay, A. K., Adams, E. R., Drakeley, C., ter Kuile, F. O., Soulama, I., Kariuki, S., Allen, D. J., Edwards, T.
10.1101/2024.04.11.24305244 — Posted: 2024-04-12
Effectiveness of the 2023-2024 Omicron XBB.1.5-containing mRNA COVID-19 vaccine (mRNA-1273.815) in preventing COVID-19-related hospitalizations and medical encounters among adults in the United States: An interim analysis
Kopel, H., Araujo, A. B., Bogdanov, A., Zeng, N., Winer, I., Winer-Jones, J. P., Lu, T., Marks, M. A., Bonafede, M., Nguyen, V. H., Martin, D., Mansi, J. A.
10.1101/2024.04.10.24305549 — Posted: 2024-04-12
Antibody Responses to SARS-Cov-2 among Health Care Workers of a Tertiary Hospital in North-Eastern, Tanzania
Ibrahim, P. M., Anthony, F., Rwegoshora, K., Mshana, H., Semvua, H., Chilongola, J.
10.1101/2024.04.09.24305582 — Posted: 2024-04-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).